7749 — Medikit Co Income Statement
0.000.00%
- ¥37bn
- ¥16bn
- ¥23bn
- 90
- 79
- 39
- 82
Annual income statement for Medikit Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19,313 | 20,131 | 21,607 | 21,851 | 22,553 |
Cost of Revenue | |||||
Gross Profit | 7,592 | 8,181 | 8,319 | 8,753 | 8,668 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,539 | 15,763 | 17,368 | 17,181 | 18,068 |
Operating Profit | 3,774 | 4,368 | 4,239 | 4,670 | 4,485 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,929 | 4,473 | 4,291 | 4,775 | 4,660 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,659 | 2,993 | 2,865 | 3,069 | 3,014 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,659 | 2,993 | 2,865 | 3,069 | 3,014 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,659 | 2,993 | 2,865 | 3,069 | 3,014 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 157 | 181 | 168 | 202 | 218 |
Dividends per Share | |||||
Special Dividends per Share |